ITRM vs PPL · rev $390.0K vs P/E 22, rev $8.46B
Iterum Therapeutics PLC (ITRM) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
ITRM currently screens at market cap $38.6M. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the ITRM and PPL stock pages for the full models.
Not investment advice.